BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Leo Cancer Care Advances Upright Radiation Therapy Experience for Children

Leo Cancer Care has announced plans to further invest in the treatment experience for children undergoing radiation therapy. Following the world's fi...

September 29, 2026 | News

Innovent Expands Global Phase III IBI363 Trial to Non-Squamous NSCLC

Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization...

September 29, 2026 | News

Akeso Enrols First Patient in Global Phase III Cadonilimab Trial for Advanced Gastric Cancer

Akeso, Inc. announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), a global, multicenter Phase III head-to-head trial evaluating ...

September 29, 2026 | News

Lundbeck Relocates US Headquarters to Greater Boston, Establishes Global Innovation Hub

The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent ...

September 28, 2026 | News

Earendil Labs, Genentech Ink $1.5B+ Deal to Develop AI-Driven Bispecific Antibodies

Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research collaboration with Genentech, a member o...

September 25, 2026 | News

Sanyou Bio, NovoCodex Join Forces to Advance Next-Generation ADC Therapeutics

Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") and NovoCodex Biopharmaceuticals Co., Ltd. ("NovoCodex") jointly announced that the two companies have f...

September 25, 2026 | News

Turbine, Daiichi Sankyo Expand Virtual Biology Collaboration to Accelerate ADC Discovery

Turbine, a leading virtual biology company, announced the expansion of its collaboration with Daiichi Sankyo following the successful completio...

September 25, 2026 | News

Bio-Techne Shareholders Approve Acquisition by Merck KGaA

Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne ...

September 25, 2026 | News

European Commission Approves First-in-Class Obicetrapib for LDL-C Reduction

- First-in-Class approval supported by Phase 3 BROADWAY, BROOKLYN, and TANDEM trials demonstrating significant LDL-C reductions with favorable tolerability...

September 25, 2026 | News

Thermo Fisher Launches CHO-K1 Media Panel to Boost Biologics Production

Thermo Fisher Scientific, the world leader in serving science, announced the Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed me...

September 24, 2026 | News

Sovargen Doses First Patient in Phase Ib/IIa Trial of Kazia’s Paxalisib for Rare Epilepsies

- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology,...

September 24, 2026 | News

Tsingke Launches High-Throughput Validation Workflow for AI-Designed Proteins and Antibodies

Tsingke announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed pro...

September 24, 2026 | News

XtalPi-Backed Viva-Thera Advances AI-Designed HIV Candidate to Preclinical Stage in Seven Months

Viva-Thera makes its public debut with four modalities pursuing HIV prevention, treatment and cure, supported by XtalPi's platform capabilities. Viva-Th...

September 24, 2026 | News

Every First Approval in APAC, 2026: The Full List

Asia-Pacific’s New Drug Boom: 99 Approvals, 20 World Firsts Somewhere in the second week of January, a BeOne Medicines BCL2 inhibitor called sonroto...

September 23, 2026 | Analysis

Stay Connected